Ovarian Neoplasms [clinicaltrials_resource:56d6f2f6af7c99df4ba7d0edab18737b]
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [clinicaltrials:NCT00001272]A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [clinicaltrials:NCT00001427]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma [clinicaltrials:NCT00034138]Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma [clinicaltrials:NCT00034372]EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer [clinicaltrials:NCT00035100]Phase 2 Study of TLK286 in Platinum Resistant Advanced Epithelial Ovarian Cancer [clinicaltrials:NCT00038428]Massage Therapy for Cancer-Related Fatigue [clinicaltrials:NCT00039793]Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer. [clinicaltrials:NCT00043446]Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk [clinicaltrials:NCT00043472]Study of OSI-211 vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer [clinicaltrials:NCT00046800]clinicaltrials:NCT00050414Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer [clinicaltrials:NCT00051584]TLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian Cancer [clinicaltrials:NCT00051948]TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer [clinicaltrials:NCT00052065]A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies [clinicaltrials:NCT00057395]TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer [clinicaltrials:NCT00057720]clinicaltrials:NCT00069160Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 To Treat Small-Volume Ovarian, Peritoneal, Fallopian Tube Cancer [clinicaltrials:NCT00074867]Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors [clinicaltrials:NCT00080041]Acupuncture for Women's Health Conditions [clinicaltrials:NCT00090389]TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer [clinicaltrials:NCT00102973]Study of Pemetrexed in the Treatment of Patients With Ovarian Cancer Who Have Failed Prior Platinum-Based Chemotherapy [clinicaltrials:NCT00109096]clinicaltrials:NCT00112086Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer [clinicaltrials:NCT00120939]Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence [clinicaltrials:NCT00123773]Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients [clinicaltrials:NCT00127920]clinicaltrials:NCT00130520clinicaltrials:NCT00132704Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer [clinicaltrials:NCT00137865]Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms [clinicaltrials:NCT00160472]clinicaltrials:NCT00178802A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. [clinicaltrials:NCT00191607]clinicaltrials:NCT00191646Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy [clinicaltrials:NCT00216645]Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers [clinicaltrials:NCT00231855]Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis [clinicaltrials:NCT00243685]Efficacy and Safety Study of ZK219477 in Patients With Recurrentovarian Cancer [clinicaltrials:NCT00246688]Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology [clinicaltrials:NCT00288821]Tissue Bank of Biological Specimens From Patients With Gynecologic Disease [clinicaltrials:NCT00299481]
condition [clinicaltrials_vocabulary:condition]
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [clinicaltrials:NCT00001272]A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer [clinicaltrials:NCT00001426]A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [clinicaltrials:NCT00001427]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]Methods in Education for Breast Cancer Genetics [clinicaltrials:NCT00001806]clinicaltrials:NCT00001827Microarray Analysis for Human Genetic Disease [clinicaltrials:NCT00001898]A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) [clinicaltrials:NCT00001938]Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer [clinicaltrials:NCT00002474]Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer [clinicaltrials:NCT00002477]Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer [clinicaltrials:NCT00002671]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00002734]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [clinicaltrials:NCT00002894]Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00002895]Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [clinicaltrials:NCT00002928]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [clinicaltrials:NCT00003072]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]clinicaltrials:NCT00003120clinicaltrials:NCT00003136Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum [clinicaltrials:NCT00003160]Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003214]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003297]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003345]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003386]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003413]Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [clinicaltrials:NCT00003449]Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003450]Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [clinicaltrials:NCT00003523]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003532]Gene Therapy in Treating Patients With Ovarian Cancer [clinicaltrials:NCT00003588]clinicaltrials:NCT00003644Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003670]
condition browse [clinicaltrials_vocabulary:condition-browse]
A Phase I Study of Taxol, Cisplatin, Cyclophosphamide and Granulocyte Colony-Stimulating Factor (G-CSF) in Previously Nontreated Ovarian Cancer Patients [clinicaltrials:NCT00001272]A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer [clinicaltrials:NCT00001426]A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin [clinicaltrials:NCT00001427]Outcomes of Education and Counseling for BRCA1 Testing [clinicaltrials:NCT00001468]Methods in Education for Breast Cancer Genetics [clinicaltrials:NCT00001806]clinicaltrials:NCT00001827Microarray Analysis for Human Genetic Disease [clinicaltrials:NCT00001898]A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) [clinicaltrials:NCT00001938]Combination Chemotherapy and Bone Marrow Transplant in Treating Patients With Refractory or Recurrent Ovarian Cancer [clinicaltrials:NCT00002474]Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer [clinicaltrials:NCT00002477]Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [clinicaltrials:NCT00002487]Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer [clinicaltrials:NCT00002671]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer [clinicaltrials:NCT00002734]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer [clinicaltrials:NCT00002894]Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00002895]Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer [clinicaltrials:NCT00002913]Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [clinicaltrials:NCT00002928]Melphalan and Thiotepa Followed by Peripheral Stem Cell Transplantation in Treating Patients With Epithelial Ovarian Cancer in Complete Remission [clinicaltrials:NCT00002977]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer [clinicaltrials:NCT00003064]Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [clinicaltrials:NCT00003072]Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer [clinicaltrials:NCT00003080]clinicaltrials:NCT00003120clinicaltrials:NCT00003136Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum [clinicaltrials:NCT00003160]Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003214]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003297]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003345]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003386]Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003413]Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer [clinicaltrials:NCT00003449]Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003450]Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [clinicaltrials:NCT00003523]Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer [clinicaltrials:NCT00003532]Gene Therapy in Treating Patients With Ovarian Cancer [clinicaltrials:NCT00003588]clinicaltrials:NCT00003644Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00003670]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Ovarian Neoplasms [clinicaltrials_resource:56d6f2f6af7c99df4ba7d0edab18737b]
Bio2RDF identifier
56d6f2f6af7c99df4ba7d0edab18737b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:56d6f2f6af7c99df4ba7d0edab18737b
identifier
clinicaltrials_resource:56d6f2f6af7c99df4ba7d0edab18737b
title
Ovarian Neoplasms
@en
type
label
Ovarian Neoplasms [clinicaltrials_resource:56d6f2f6af7c99df4ba7d0edab18737b]
@en
Ovarian Neoplasms